New Market Research Report Added In MarketResearchReports.Biz Reports Database Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
Albany, NY -- (SBWIRE) -- 01/25/2013 -- Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
To Buy a Copy Of This Report: http://www.marketresearchreports.biz/analysis-details/inherited-orphan-blood-disorders-therapeutics-market-to-2019-breakthrough-drugs-remain-elusive-against-backdrop-of-high-unmet-need
GBI Research, the leading business intelligence provider, has released its latest research, Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need. The report provides insights into the up-and-coming trends of a portion of the inherited orphan blood disorder pharmaceutical market by examining sickle cell anemia, thalassemia and Hereditary Angioedema (HAE) in seven major markets: the US, the top five European countries (France, Germany, Italy, Spain and the UK) and Japan. The report includes market forecasts to 2019, detailed pipeline analysis, in-depth profiling of major products and details of recent industry deals.
For All Reports Kindly Visit: http://www.marketresearchreports.biz/
The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts.
The sickle cell anemia market will be the fastest growing of the three markets during the forecast period with a Compound Annual Growth Rate (CAGR) of 9% seeing it reach $70m in 2019. The thalassemia market will grow at a lower CAGR of 7% to reach $59m in 2019. HAE represents the largest but slowest growing market, expected to reach $1.89 billion by 2019 at a CAGR of 3%.
To Read The Complete Report with TOC: http://www.marketresearchreports.biz/analysis/160071
- Current and future treatment trends for three rare diseases
- Market forecasts for three rare diseases across seven major markets
- Analysis of the developmental pipelines for three rare diseases
- Information on recent industry deals
Reasons to buy
- Understand how the inherited orphan blood diseases market has developed and is continuing to develop within the featured markets
- Predict which products are likely to be most successful in the future
- Gain an understanding of the possible market available for specific products
Latest Reports :
Dental Implants Market to 2018 - Technical Advancements and Procedure Efficiency are Resulting in the Increased Preference for Dental Implants over Traditional Dental Devices: http://www.marketresearchreports.biz/analysis/160072
Opioids Market to 2018 - Increasing Concentration of Abuse-Resistant Branded Generics Alter Competitive Dynamics in this Flat Market: http://www.marketresearchreports.biz/analysis/158132